Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 55Colonic Neoplasms 22Adenoma 16Colonic Polyps 13Polyps 7Colorectal Neoplasms, Hereditary Nonpolyposis 6Neoplasms 5Adenomatous Polyps 5Rectal Neoplasms 4Pain 4Disease 4Colitis, Ulcerative 2Anus Neoplasms 2Adenomatous Polyposis Coli 2Turcot syndrome 1Recurrence 1Personal Satisfaction 1Patient Satisfaction 1Pathologic Complete Response 1Lymphoma, Mantle-Cell 1Li-Fraumeni Syndrome 1Irritable Bowel Syndrome 1Intestinal Neoplasms 1Inflammatory Bowel Diseases 1Hyperplasia 1Hamartoma Syndrome, Multiple 1HIV Infections 1Gastrointestinal Neoplasms 1Diverticulitis, Colonic 1Diverticulitis 1

Interventions

Doxorubicin 20Vincristine 17Zidovudine 13Cyclophosphamide 12Bleomycin 12Etoposide 10Rituximab 6Prednisone 6Interferon alpha-2 6Cytarabine 6Liposomes 5Filgrastim 5Dexamethasone 5tecogalan 4sargramostim 4Specimen Handling 4Methotrexate 4Magnetic Resonance Spectroscopy 4Leucovorin 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Fluorouracil 4Biopsy 4Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Nivolumab 3interferon alfa-n1 2fludarabine phosphate 2fludarabine 2cabozantinib 2Whole-Body Irradiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Infections × Colonoscopy × Clear all
NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡